The Capecitabine Global Market Report 2023, provides comprehensive information on the capecitabine market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Capecitabine Market’s Growth:
https://www.thebusinessresearchcompany.com/report/capecitabine-global-market-report
The global
capecitabine market is expected to grow from $1.88 billion in 2022 to $2.06
billion in 2023 at a compound annual growth rate (CAGR) of 9.5%. The
Russia-Ukraine war disrupted the chances of global economic recovery from the
COVID-19 pandemic. The war between these two countries has led to economic
sanctions on multiple countries, a surge in commodity prices, and supply chain
disruptions, causing inflation across goods and services and affecting many
markets across the globe. The market size of global capecitabine is expected to
reach $2.88 billion in 2027 at a CAGR of 8.8%.
Get A Free Sample Of The Report (Includes Graphs And
Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12240&type=smp
Developing novel
therapies has emerged as a key trend gaining popularity in the capecitabine
market. Major players operating in the capecitabine market are concentrating on
creating advanced treatments in combination with capecitabine to strengthen
their position in the market. For instance, in April 2020, Seagen Inc., a
US-based biotechnology company, introduced TUKYSA (tucatinib), the first HER-2
tyrosine kinase inhibitor approved in combination with capecitabine and
trastuzumab to treat HER2-positive metastatic breast cancer. It has anti-tumor
action in HER2-positive cancer cells. When combined with the anti-HER2
antibodies trastuzumab and capecitabine, the medication demonstrated greater
anti-tumor efficacy both in vivo and in vitro when compared to either treatment
alone. It resulted in a verified objective response rate (ORR) of 40.6%, while
trastuzumab and capecitabine alone resulted in an ORR of 22.8%.
The capecitabine
market is segmented:
1) By Drug Type:
Branded, Generic
2) By Drug
Formulation: Tablet, Capsules
3) By
Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
4) By
Application: Colon Cancer, Rectal Cancer, Breast Cancer, Gastric Cancer, Other
Applications
5) By End-Users:
Hospitals, Homecare, Specialty Centers, Other End-Users
North America was
the largest region in the capecitabine market in 2022.
The table of contents in TBRC’s capecitabine market report includes:
1. Executive Summary
2. Capecitabine Market Characteristics
3. Capecitabine Market Trends And Strategies
4. Capecitabine Market - Macro Economic Scenario
5.Global Capecitabine Historic Market Size and Growth
.
32. Global Capecitabine Market Competitive Benchmarking
33. Global Capecitabine Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Capecitabine Market
35. Capecitabine Market Future Outlook and Potential Analysis
36. Appendix
Learn About Us:
The Business Research Company is a market intelligence
firm that pioneers in market, company, and consumer research. TBRC’s specialist
consultants are located globally and are experts in a wide range of industries
that include healthcare, manufacturing, financial services, chemicals, and
technology. The firm has offices located in the UK, the US, and India, along
with a network of proficient researchers in 28 countries. Through the report
businesses can gain a thorough understanding of the market’s size, growth rate,
major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market
Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment